Filing Flows › Lifecore Biomedical (LFCR) › Stock forecast & fair value
Lifecore Biomedical (LFCR) stock forecast and price target
Lifecore Biomedical (LFCR) trades at $6.36. The analysts' price target is $6.28 (-1%).
Lifecore Biomedical's latest quarter
Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for LFCR stock?
The analysts' 12-month target is $6.28, -1% from $6.36. The average rating is none.
Does Lifecore Biomedical usually beat earnings estimates?
It beat the consensus EPS estimate in 20% of the quarters on record.
Is LFCR stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.